BridgeMD
Evaluation of patients with total coronary occlusions with multimodality image.
EU CTIS ID: 2024-519979-26-00
What this study is testing
Evaluate the concordance between coronary CT angiography with myocardial perfusion imaging at stress and rest and stress cardiac MRI for the detection of ischemia and viability in patients with chronic total occlusion (CTO).
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Chronic total occlusion in a native coronary artery
- Age 18 years or older
- Distal vessel to the chronic occlusion with a diameter of at least 2.5 mm
- Ability to provide informed consent and willingness to comply with the follow-up protocol
You likely can't join if
- Multivessel disease with incomplete revascularization in the artery without chronic total occlusions.
- Severe valvular disease requiring surgery.
- Allergy to iodinated contrast.
- Previous revascularization surgery in the artery with chronic total occlusion.
- Acute myocardial infarction within the past 3 months.
- Coronary anatomy not favorable for percutaneous revascularization of the chronic total occlusion.
See the full eligibility criteria
- Chronic total occlusion in a native coronary artery
- Age 18 years or older
- Distal vessel to the chronic occlusion with a diameter of at least 2.5 mm
- Ability to provide informed consent and willingness to comply with the follow-up protocol
- Multivessel disease with incomplete revascularization in the artery without chronic total occlusions.
- Severe valvular disease requiring surgery.
- Allergy to iodinated contrast.
- Previous revascularization surgery in the artery with chronic total occlusion.
- Acute myocardial infarction within the past 3 months.
- Coronary anatomy not favorable for percutaneous revascularization of the chronic total occlusion.
- Coronary artery disease involving the left main or three vessels requiring surgery as assessed by the multidisciplinary team.
- Life expectancy less than 2 years.
- Severe chronic renal insufficiency (glomerular filtration rate ≤ 30 mL/min).
- Contraindication to dual antiplatelet therapy.
- Pregnancy.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.